ORKA ▼ -0.6% - Oruka Therapeutics, Inc. $ORKA - Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing Oruka Therapeutics announced positive Week 28 data from its EVERLAST-A trial for ORKA-001, demonstrating that treatment responses continued to deepen without requiring additional dosing. Despite the favorable clinical results, the stock declined 0.6% today, suggesting investors may have been pricing in positive data or had other concerns offsetting the announcement. 23-SEP-2026 07:00 AM ET